Table 4 KEGG signaling pathways that are significantly associated with mRNAs in the co-expression network
Term | Count | P value | Genes |
|---|---|---|---|
hsa00020:Citrate cycle (TCA cycle) | 2 | 1.15E−02 | SUCLG2, IDH1 |
hsa05200:Pathways in cancer | 4 | 1.35E−02 | E2F1, MAX, MITF, CTNNA1 |
hsa04080:Neuroactive ligand-receptor interaction | 3 | 2.67E−02 | ADORA2B, GRIK3, OXTR |
hsa04270:Vascular smooth muscle contraction | 2 | 3.60E−02 | ADORA2B, ARHGEF12 |
hsa04530:Tight junction | 2 | 4.14E−02 | PARD6G, CTNNA1 |
hsa04020:Calcium signaling pathway | 2 | 4.51E−02 | ADORA2B, OXTR |